browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
dcd7521a-5037-4ae0-85ac-b59569500a8b
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 17:48:04
Income (reported)
$50,000
Expenses (reported)
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

WILLIAMS AND JENSEN, PLLC

Lobbying Law Firm

Contact
ISABELLA QUINN
Phone
+1 202-659-8201
Address
zip:20004, city:Washington, state:DC, street:1201 Pennsylvania Avenue, NW Suite 800
Client

PHRMA

Represents country's leading pharmaceutical research and biotechnology companies

State
DC
Country
US
Government-entity client
false
Effective date
2011-01-01
Issues lobbied + lobbyists (5)

MMM — Medicare/Medicaid

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing proposal, Medicare Rebate Rule. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 1492 and S. 832. H.R. 1, "One Big Beautiful Bill Act", issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. Drug pricing legislation, Medicare rebate reform, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). Pharmacy benefit manager reform proposals. H.R. 1492 and S. 832.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

BUD — Budget/Appropriations

Issues related to pharmaceutical development; Policies impacting Medicare Part D; Part B and 340 B programs.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

DEF — Defense

Issues related to pharmaceutical manufacturing and development.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TRD — Trade (domestic/foreign)

IP Protections related to trade agreements; trade policies impacting pharmaceutical development; potential tariff actions under Section 232 of the Trade Act of 1962. Legislative proposals related to WTO TRIPS Waiver.

Lobbyists:
  • SUSAN HIRSCHMANN
  • mr MATTHEW B HOEKSTRA
  • JEANNE HAGGERTY — covered position: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.